Antimetabolite radiosensitizers
DS Shewach, TS Lawrence - Journal of Clinical Oncology, 2007 - ascopubs.org
Radiosensitization with antimetabolites has improved clinical outcome for patients with solid
malignancies, especially cancers of the GI tract, cervix, and head and neck. Fluorouracil …
malignancies, especially cancers of the GI tract, cervix, and head and neck. Fluorouracil …
Antisense inhibition of microRNA-21 or-221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma
JK Park, EJ Lee, C Esau, TD Schmittgen - Pancreas, 2009 - journals.lww.com
Objectives: The contribution of overexpressed microRNA-21 and-221 (miR-21 and miR-221)
to the malignant phenotype was determined by inhibiting these miRNAs using antisense …
to the malignant phenotype was determined by inhibiting these miRNAs using antisense …
Mechanisms of resistance to EGFR tyrosine kinase inhibitors and therapeutic approaches: an update
A Ahsan - Lung Cancer and Personalized Medicine: Current …, 2016 - Springer
Resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in
non small cell lung cancer (NSCLC) is mediated by two major mechanisms namely …
non small cell lung cancer (NSCLC) is mediated by two major mechanisms namely …
Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells
Receptor tyrosine kinases (RTK) are therapeutic targets for the treatment of malignancy.
However, tumor cells develop resistance to targeted therapies through the activation of …
However, tumor cells develop resistance to targeted therapies through the activation of …
ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage
A Chakraborty, KA Dorsett, HQ Trummell… - Journal of Biological …, 2018 - ASBMB
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor
prognosis. Gemcitabine, as a single agent or in combination therapy, remains the frontline …
prognosis. Gemcitabine, as a single agent or in combination therapy, remains the frontline …
Mechanism mediating oligomeric Aβ clearance by naïve primary microglia
CN Yang, YJ Shiao, FS Shie, BS Guo, PH Chen… - Neurobiology of …, 2011 - Elsevier
The accumulation of soluble oligomeric amyloid-β peptide (oAβ) proceeds the formation of
senile plaques and contributes to synaptic and memory deficits in Alzheimer's disease (AD) …
senile plaques and contributes to synaptic and memory deficits in Alzheimer's disease (AD) …
KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradation
Attempts to target mutant KRAS have been unsuccessful. Here, we report the identification of
Smad ubiquitination regulatory factor 2 (SMURF2) and UBCH5 as a critical E3: E2 complex …
Smad ubiquitination regulatory factor 2 (SMURF2) and UBCH5 as a critical E3: E2 complex …
Synergistic inhibition of head and neck tumor growth by green tea (−)‐epigallocatechin‐3‐gallate and EGFR tyrosine kinase inhibitor
X Zhang, H Zhang, M Tighiouart, JE Lee… - … journal of cancer, 2008 - Wiley Online Library
One of the mechanisms of the antitumor activity of green tea (−)‐epigallocatechin‐3‐gallate
(EGCG) is associated with its effect on epidermal growth factor receptor (EGFR)‐mediated …
(EGCG) is associated with its effect on epidermal growth factor receptor (EGFR)‐mediated …
Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway
J Okano, T Nagahara, K Matsumoto… - Basic & clinical …, 2008 - Wiley Online Library
Caffeine has been reported to prevent hepatocarcinogenesis. We investigated the molecular
mechanisms by which caffeine inhibits the growth of hepatocellular carcinoma (HCC) cells …
mechanisms by which caffeine inhibits the growth of hepatocellular carcinoma (HCC) cells …
Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors
RJ Leeman-Neill, Q Cai, SC Joyce, SM Thomas… - Clinical Cancer …, 2010 - AACR
Purpose: This study aimed to investigate the utility of honokiol, a naturally occurring
compound, in the treatment of head and neck squamous cell carcinoma (HNSCC) as well as …
compound, in the treatment of head and neck squamous cell carcinoma (HNSCC) as well as …